Position in OLMA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,727,560
-$9,734,690 QoQ
Shares Held
182,935
-63.3% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Derivatives in OLMA
reported options exposure · as of Sep 30, 2021CallValue
$275,600
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in OLMA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,727,560 | 182,935 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,462,250 | 498,490 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,244,934 | 331,454 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,414,843 | 1,271,090 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,680,468 | 978,848 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,708,846 | 979,219 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $932,036 | 78,060 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $999,069 | 88,257 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,224,145 | 87,252 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,644,060 | 214,094 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,416,039 | 267,557 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $261,027 | 75,224 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,803,084 | 735,953 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,872,930 | 678,598 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,618,410 | 643,344 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $363,876 | 85,417 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,324,350 | 248,328 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $275,600 | 10,000 | Call | Sole | 2021-11-15 | |
| 2020-12-31 | $892,028 | 18,553 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||